These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 2068463)
1. Aztreonam in the treatment of gram-negative bacterial meningitis. Lentnek AL; Williams RR Rev Infect Dis; 1991; 13 Suppl 7():S586-90. PubMed ID: 2068463 [TBL] [Abstract][Full Text] [Related]
2. Aztreonam in the treatment of gram-negative meningitis in children. Isani Z; Rehman N; Adil N; el Messidi M Chemioterapia; 1987 Jun; 6(2 Suppl):428-30. PubMed ID: 3334590 [No Abstract] [Full Text] [Related]
3. Aztreonam in the treatment of gram-negative meningitis and other gram-negative infections. Feris J; Moledina N; Rodriguez WJ; Khan WN; Puig J; Wiedermann BL; Ahmad S Chemotherapy; 1989; 35 Suppl 1():31-8. PubMed ID: 2731448 [TBL] [Abstract][Full Text] [Related]
9. Aztreonam for treating meningitis caused by gram-negative rods. Kilpatrick M; Girgis N; Farid Z; Bishay E Scand J Infect Dis; 1991; 23(1):125-6. PubMed ID: 2028226 [TBL] [Abstract][Full Text] [Related]
10. [Cefotaxime in the treatment of purulent meningitis in children (author's transl)]. Borderon JC; Despert F; Santini JJ; Laugier J; Grenier B; Boulard P Nouv Presse Med; 1981 Feb; 10(8):634-8. PubMed ID: 6259609 [TBL] [Abstract][Full Text] [Related]
11. Parenteral aztreonam in the treatment of Haemophilus influenzae type b meningitis in Egyptian children. Girgis NI; Abu el Ella AH; Farid Z; Woody JN; Haberberger RL; el Messidy M; Dessouky A Scand J Infect Dis; 1988; 20(1):111-2. PubMed ID: 3259009 [TBL] [Abstract][Full Text] [Related]
12. Comparison of empiric aztreonam and aminoglycoside regimens in the treatment of serious gram-negative lower respiratory infections. Bjornson HS; Ramirez-Ronda C; Saavedra S; Rivera-Vázquez CR; Liu C; Hinthorn DR Clin Ther; 1993; 15(1):65-78. PubMed ID: 8458056 [TBL] [Abstract][Full Text] [Related]
13. [What is safe in the therapy of purulent meningitis?]. Rosin H Internist (Berl); 1981 Dec; 22(12):739-43. PubMed ID: 7033164 [No Abstract] [Full Text] [Related]
14. Comparative evaluation of aztreonam in therapy for experimental bacterial meningitis and cerebritis. Scheld WM; Brodeur JP; Foresman PA; Gratz JC; Rodeheaver GT Rev Infect Dis; 1985; 7 Suppl 4():S635-47. PubMed ID: 3909319 [TBL] [Abstract][Full Text] [Related]
15. Treatment of bacterial meningitis with ceftazidime. Hatch D; Overturf GD; Kovacs A; Forthal D; Leong C Pediatr Infect Dis; 1986; 5(4):416-20. PubMed ID: 3523458 [TBL] [Abstract][Full Text] [Related]
16. Moxalactam for the treatment of bacterial meningitis in children. Freedman JM; Hoffman SH; Scheld WM; Lynch MA; da Silva HR; Rocha H; Sande MA J Infect Dis; 1983 Nov; 148(5):886-91. PubMed ID: 6415181 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of aztreonam in the treatment of patients with renal failure. Sion ML; Pyrpasopoulos M; Nicolaidis P; Papagianni C; Tsurutsoglu G Rev Infect Dis; 1991; 13 Suppl 7():S652-4. PubMed ID: 2068477 [TBL] [Abstract][Full Text] [Related]
19. Overall clinical experience with aztreonam in the treatment of intraabdominal infections. Henry SA Rev Infect Dis; 1985; 7 Suppl 4():S729-33. PubMed ID: 3909331 [TBL] [Abstract][Full Text] [Related]
20. Effectiveness of cefotaxime in gram-negative meningitis. LeFrock JL; Molavi A; Smith B; Black P; Rosenberg M; Rolston K; Brodner R; Chandrasekar P; Henao L; Kannangara DW Neurosurgery; 1984 Nov; 15(5):679-82. PubMed ID: 6095133 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]